Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® Highlights Products at AACC 2014

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
The products to be featured at the meeting offer unique solutions for the clinical market.

WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These products showcase the company’s ongoing commitment to provide a range of distinctive products that provide solutions to the growing clinical testing sector.
 
WHEATON’S CryoElite Tissue Vials are designed for the safe, secure and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers a uniform vial able to maintain sample integrity while maximizing storage capacity and organization. CryoElite Tissue Vials were developed with input from industry thought leaders for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations and biorepository and biobanking facilities. They offer researchers and clinicians who work with biological specimens ease of use, convenience and security for their precious samples.
 
MicroLiter Chromatography Vials are the industry’s most versatile and innovative, designed for high precision, trouble-free operation for both GC and HPLC applications. All MircroLiter Vials are Class 10,000 clean room packed, making them the clear choice for challenging clinical LOD and LOQ assays and limited quantity specimens and unknown targets.   A complete range of size and closure types are available, designed to the tightest tolerances to ensure that they exceed all autosampler specifications.  When high throughput applications require the use of glass vials, the MicroLiter MPSS allows for robotic liquid handling with the patented “uLmat” that eliminates leakage and cross contamination between wells.
 
Our line of High Recovery Vials has a unique patented interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
 
“We are investing substantial resources to better understand the specific needs of the clinical lab customer and create product solutions addressing those needs, by incorporating innovative, value-added features that help them do their jobs more effectively and efficiently,” said Wayne L. Brinster, CEO and President of WHEATON. “Our CryoElite Tissue Vials provide crucial performance advantages to the rapidly growing tissue banking field; our High Recovery Vials offer much-needed efficiencies to users of high value reagents; and our high precision, versatile, easy to use MicroLiter Chromatography Vials and other WHEATON specialty products show how our 125-year commitment to ongoing innovation and excellence help bring the benefits of scientific advances to our customers and all those they serve.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wayne Brinster Joins WHEATON® as President
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.
Friday, October 26, 2012
Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!